MK-7602 Multiple Ascending Dose Study in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503738-36-00

Acronym

MK-7602-002

Enrollment

Registered

2023-05-02

Start date

2023-05-12

Completion date

2023-11-09

Last updated

2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026